Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemours (CC) EBT Margin (2016 - 2025)

Historic EBT Margin for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to 3.41%.

  • Chemours' EBT Margin rose 55300.0% to 3.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.67%, marking a year-over-year decrease of 42900.0%. This contributed to the annual value of 1.83% for FY2024, which is 123300.0% up from last year.
  • According to the latest figures from Q3 2025, Chemours' EBT Margin is 3.41%, which was up 55300.0% from 16.16% recorded in Q2 2025.
  • Chemours' 5-year EBT Margin high stood at 19.17% for Q4 2021, and its period low was 26.08% during Q2 2023.
  • Over the past 5 years, Chemours' median EBT Margin value was 3.41% (recorded in 2025), while the average stood at 3.02%.
  • As far as peak fluctuations go, Chemours' EBT Margin tumbled by -381500bps in 2023, and later skyrocketed by 305200bps in 2024.
  • Chemours' EBT Margin (Quarter) stood at 19.17% in 2021, then crashed by -127bps to 5.16% in 2022, then dropped by -1bps to 5.19% in 2023, then surged by 113bps to 0.66% in 2024, then surged by 415bps to 3.41% in 2025.
  • Its EBT Margin stands at 3.41% for Q3 2025, versus 16.16% for Q2 2025 and 0.95% for Q1 2025.